Wunderlich Capital Managemnt’s Biogen BIIB Stock Holding History

Wunderlich Capital Managemnt’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-4,749	Closed	-$1.3M	–	90
2018 Q1	$1.3M	Buy	4,749 +39	+0.8%	+$12.1K	0.89%	64
2017 Q4	$1.5M	Buy	4,710 +587	+14%	+$188K	1.04%	50
2017 Q3	$1.29M	Buy	+4,123	New	+$1.22M	0.96%	57
2015 Q4	–	Sell	-3,850	Closed	-$1.12M	–	95
2015 Q3	$1.12M	Buy	3,850 +20	+0.5%	+$6.61K	1.04%	52
2015 Q2	$1.55M	Sell	3,830 -27	-0.7%	-$10.8K	1.5%	14
2015 Q1	$1.62M	Sell	3,857 -32	-0.8%	-$12.6K	1.46%	13
2014 Q4	$1.32M	Buy	3,889 +167	+4%	+$54K	1.12%	46
2014 Q3	$1.23M	Buy	3,722 +49	+1%	+$16.2K	1.1%	40
2014 Q2	$1.16M	Buy	+3,673	New	+$1.11M	1.06%	56

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wunderlich Capital Managemnt's BIIB Position: Q2 2018 in Review

Wunderlich Capital Managemnt sold out of Biogen (BIIB) in Q2 2018, closing a stake of 4,749 shares — an estimated $1.3M sold.

Wunderlich Capital Managemnt first reported a position in BIIB in Q2 2014 and held it in 9 quarters. The position peaked at $1.62M in Q1 2015. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q2 2018.

Wunderlich Capital Managemnt reported no remaining Biogen position as of Q2 2018 after selling out during the quarter.
Wunderlich Capital Managemnt sold 4,749 Biogen shares in Q2 2018, an estimated $1.3M.
Wunderlich Capital Managemnt first reported a position in Biogen in Q2 2014 and held it in 9 quarters.
Wunderlich Capital Managemnt's Biogen position peaked at $1.62M in Q1 2015.
1,098 funds tracked by Wall St. Rank held Biogen as of Q2 2018.

Based on Wunderlich Capital Managemnt's 13F filing for Q2 2018, filed 14 Aug 2018.